ARCHIVES

Taxol Recommended For Second Line Therapy In Platinum-Resistant Metastatic Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 18 No. 45 | November 20, 1992

Download PDF Visit The Full Archive

Related Articles

DCPC Board Votes To Keep Women’s Health Trial Alive, At Least For Now; Issue Goes To NCAB

September 25, 1987

NCI Advisory Group, Other Cancer Meetings

April 29, 1983

Breast Cancer Death Rates Improving, NCI Says

May 10, 1996

In Brief: Two New Section Chiefs Named In NCI Research Contracts Branch; S. 988 Markup Set For April 25

April 18, 1980

In Brief: Shannn Award Selections Made; ACS Funds 431 Grants Worth $50 Mil.; 500 Nurses Pass Exam

August 30, 1991

AIDS Biological Specimens Available From NIH

November 22, 1985